All articles tagged with #pde5
A Weizmann Institute study (with U.S. data) suggests sildenafil (Viagra) can limit cancer’s ability to metastasize by disrupting cholesterol use inside cells via PDE5 inhibition and higher cGMP; researchers propose combining Viagra-related drugs with statins to slow spread. However, findings are observational and based on mouse data, so not yet proven in humans.
A Weizmann Institute study suggests sildenafil (Viagra’s active ingredient) may slow cancer metastasis by disrupting how cancer cells use cholesterol, potentially reducing the spread to distant tumors. The work combines human data, cell and mouse experiments, and suggests that pairing PDE5 inhibitors with statins could help limit tumor spread, but the human evidence is observational and does not prove causation; more research is needed before clinical application.
A study led by the Weizmann Institute of Science suggests sildenafil (Viagra) may prevent cancer cells from spreading by causing cholesterol to accumulate in recycling compartments, depriving tumors of cholesterol needed for invasion; while promising, clinical trials are needed to confirm it can reduce metastasis in patients.
A new study suggests that Viagra, a drug commonly used to treat erectile dysfunction, may reduce the risk of Alzheimer's disease by 60%. Researchers found that Viagra blocks an enzyme called PDE5, which is significantly increased in the brains of Alzheimer's patients. The drug also increases blood supply, potentially improving brain health and treating dementia. Another study revealed that Viagra lowers the risk of heart disease in men by up to 39% and reduces the risk of early death.